Olivia Newton-John Cancer Wellness and Research Centre

OrgUnit's Researchers
(Persons)

Results 1-5 of 45 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Berlangieri, AlexandraAlexandra.BERLANGIERI@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Berry, ColleenColleen.BERRY@austin.org.au
Brown, KerrynKez.Brown@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 641-660 of 927 (Search time: 0.012 seconds).

Publication YearTitleAuthor(s)
641Feb-2021Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.Bhurani, Mansi; Admojo, Lorenz; Van Der Weyden, Carrie; Twigger, Robert; Bazargan, Ali; Quach, Hang; Zimet, Allan; Coyle, Luke; Lindsay, Julian; Radeski, Dejan; Hawkes, Eliza A ; Kennedy, Glen; Irving, Ian; Gutta, Naadir; Trotman, Judith; Yeung, James; Dunlop, Lindsay; Hua, Minh; Giri, Pratyush; Yuen, Sam; Panicker, Shyam; Moreton, Susan; Khoo, Liane; Scott, Ashleigh; Kipp, David; McQuillan, Andrew; McCormack, Chris; Dickinson, Michael; Prince, Henry Miles
6421-Jan-2021Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.Schmoll, Hans-Joachim; Stein, Alexander; Van Cutsem, Eric; Price, Timothy; Hofheinz, Ralf D; Nordlinger, Bernard; Daisne, Jean-François; Janssens, Jos; Brenner, Baruch; Reinel, Hans; Hollerbach, Stephan; Caca, Karel; Fauth, Florian; Hannig, Carla V; Zalcberg, John; Tebbutt, Niall C ; Mauer, Murielle E; Marreaud, Sandrine; Lutz, Manfred P; Haustermans, Karin
643Nov-2023Pre-medical emergency team activations - Patient characteristics, outcomes and predictors of deterioration.Tan, Sing Chee; Hayes, Lachlan; Cross, Anthony; Tacey, Mark ; Jones, Daryl A 
64414-Jul-2023Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.Wichmann, Christian Werner; Burvenich, Ingrid Julienne Georgette; Guo, Nancy; Rigopoulos, Angela; McDonald, Alexander; Cao, Diana; O'Keefe, Graeme Joseph; Gong, Sylvia Jie; Gan, Hui K ; Scott, Fiona Elizabeth; Pore, Nabendu; Coats, Steven; Scott, Andrew Mark
64515-Aug-2008Predicting clinical outcome through molecular profiling in stage III melanoma.John, Thomas ; Black, Michael A; Toro, Tumi T; Leader, Debbie; Gedye, Craig A; Davis, Ian D; Guilford, Parry J; Cebon, Jonathan S 
6468-Jul-2021Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma.Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey 
6471-Oct-2022Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX.van Dijk, Erik; van Werkhoven, Erik; Asher, Rebecca; Mooi, Jennifer K ; Espinoza, David; van Essen, Hendrik F; van Tinteren, Harm; van Grieken, Nicole C T; Punt, Cornelis J A; Tebbutt, Niall C ; Ylstra, Bauke
64828-Dec-2016Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)Rummel, M; Kim, TM; Aversa, F; Brugger, W; Capochiani, E; Plenteda, C; Re, F; Trask, P; Osborne, S; Smith, R ; Grigg, Andrew P 
649Jun-2020Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.Brockwell, Natasha K; Alamgeer, Muhammad; Kumar, Beena; Rivalland, Gareth; John, Thomas ; Parker, Belinda S
65013-May-2018Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.Anderson, Nigel J; Jackson, James E; Smith, Jennifer G; Wada, Morikatsu ; Schneider, Michal; Poulsen, Michael; Rolfo, Maureen; Fahandej, Maziar; Gan, Hui K ; Joon, Daryl Lim; Khoo, Vincent
65120-Nov-2014Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.Chia, Puey Ling ; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
652May-2021Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.Lee, Sze Ting ; Muralidharan, Vijayaragavan ; Tebbutt, Niall C ; Wong, P; Fang, C; Liu, Z; Gan, Hui K ; Sachinidis, J; Pathmaraj, Kunthi ; Christophi, Christopher ; Scott, Andrew M 
65321-May-2007Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M 
6542017Prevalence, perceptions and predictors of alcohol consumption and abstinence among South Australian school students: a cross-sectional analysis.Bowden, Jacqueline A; Delfabbro, Paul; Room, Robin; Miller, Caroline L; Wilson, Carlene J 
655Feb-2016Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Doan, Tan N; Kirkpatrick, Carl M J; Walker, Patricia; Slavin, Monica A; Ananda-Rajah, Michelle R; Morrissey, C Orla; Urbancic, Karen F ; Grigg, Andrew P ; Spencer, Andrew; Szer, Jeffrey; Seymour, John F; Kong, David C M
656May-2022Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settingsParakh, Sagun ; Gan, Hui K 
65725-Dec-2020Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.Straus, David; Collins, Graham; Walewski, Jan; Zinzani, Pier Luigi; Grigg, Andrew P ; Sureda, Anna; Illes, Arpad; Kim, Tae Min; Alekseev, Sergey; Specht, Lena; Buccheri, Valeria; Younes, Anas; Connors, Joseph; Forero-Torres, Andres; Fenton, Keenan; Gautam, Ashish; Purevjal, Indra; Liu, Rachael; Gallamini, Andrea
6581-Jun-2021Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.Yin, Jun; Cohen, Romain; Jin, Zhaohui; Liu, Heshan; Pederson, Levi; Adams, Richard; Grothey, Axel; Maughan, Timothy S; Venook, Alan; Van Cutsem, Eric; Punt, Cornelis; Koopman, Miriam; Falcone, Alfredo; Tebbutt, Niall C ; Seymour, Matthew T; Bokemeyer, Carsten; Rubio, Eduardo Diaz; Kaplan, Richard; Heinemann, Volker; Chibaudel, Benoist; Yoshino, Takayuki; Zalcberg, John; Andre, Thierry; De Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef
6591-Nov-2018The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.Mooi, Jennifer K ; Wirapati, P; Asher, R; Lee, C K; Savas, P S; Price, T J; Townsend, A; Hardingham, J; Buchanan, D; Williams, D ; Tejpar, S; Mariadason, John M ; Tebbutt, Niall C 
660Nov-2023The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.Allan, Zexi; Witts, Sasha; Tie, Jeanne; Tebbutt, Niall C ; Clemons, Nicholas J; Liu, David Shi Hao